Pittsburgh, PA, United States of America

Prolx Pharmaceuticals Corporation

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 66.7

Forward Citations = 40

Loading Chart...

6 inventors (with patents filed for the assignee):

Garth Powis (4 out of 22 patents)

Lynn D Kirkpatrick (3 out of 4 patents)

Peter Wipf (2 out of 85 patents)

4. D Lynn Kirkpatrick (2 out of 2 patents)

5. Sarah J Welsh (1 out of 1 patent)

6. Linda Anne Pestano (1 out of 5 patents)

6 patents: Sort by Forward Citations

1. 7629128 - Methods of identifying respondents to hypoxia inducible factor 1-α inhibitors (2009-12-08),

2. 7446124 - Wortmannin analogs and methods of using same in combination with chemotherapeutic agents (2008-11-04),

3. 7399785 - N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor (2008-07-15),

4. 7081475 - Wortmannin analogs and methods of using same (2006-07-25),

5. 6552060 - Asymmetric disulfides and methods of using same (2003-04-22),

6. 6372772 - Inhibitors of redox signaling and methods of using same (2002-04-16),

Company Overview

Prolx Pharmaceuticals Corporation is a leading biopharmaceutical company dedicated to developing innovative therapies for rare diseases. With a focus on precision medicine, we strive to improve the lives of patients through cutting-edge research and development. Our team of experienced scientists and clinicians work tirelessly to create novel treatments that address unmet medical needs in various therapeutic areas. Visit our website to learn more about our pipeline of promising drug candidates and ongoing clinical trials.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#246 in Pittsburgh, PA

#1,627 in Pennsylvania

#45,068 in US

Pittsburgh, PA, United States of America